Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2004 Feb 01;1413:508-16. doi: 10.1038/sj.bjp.0705644.
Show Gene links
Show Anatomy links
Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.
Feng B
,
Tse HW
,
Skifter DA
,
Morley R
,
Jane DE
,
Monaghan DT
.
???displayArticle.abstract???
(2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid (PBPD) is a moderate affinity, competitive N-methyl-d-aspartate (NMDA) receptor antagonist with an atypical pattern of selectivity among NMDA receptor 2 subunit (NR2) subunits. We now describe the activity of several derivatives of PBPD tested at both rat brain NMDA receptors using l-[3H]-glutamate binding assays and at recombinant receptors expressed in Xenopus oocytes. Substituting various branched ring structures for the biphenyl group of PBPD reduced NMDA receptor activity. However, substituting linearly arranged ring structures - fluorenone or phenanthrene groups - retained or enhanced activity. Relative to PBPD, the phenanthrene derivative (2S*, 3R*)-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid (PPDA) displayed a 30- to 78-fold increase in affinity for native NMDA receptors. At recombinant receptors, PPDA displayed a 16-fold (NR2B) to 94-fold (NR2C) increase in affinity over PBPD. Replacement of the biphenyl group of PBPD with a 9-oxofluorene ring system resulted in small changes in receptor affinity and subtype selectivity. 2'-Bromo substitution on the biphenyl group of PBPD reduced antagonist affinity 3- to 5-fold at NR2A-, NR2B- and NR2D-containing receptors, but had little effect on NR2C-containing receptors. In contrast, 4'-fluoro substitution of the biphenyl ring of PBPD selectively increased NR2A affinity. The aromatic rings of PBPD and PPDA increase antagonist affinity and appear to interact with a region of the NMDA receptor displaying subunit heterogeneity. PPDA is the most potent and selective NR2C/NR2D-preferring antagonist yet reported and thus may be useful in defining NR2C/NR2D function and developing related antagonists with improved NMDA receptor subtype selectivity. British Journal of Pharmacology (2004) 141, 508-516. doi:10.1038/sj.bjp.0705644
Armstrong,
Structure of a glutamate-receptor ligand-binding core in complex with kainate.
1998, Pubmed
Armstrong,
Structure of a glutamate-receptor ligand-binding core in complex with kainate.
1998,
Pubmed
Auberson,
5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition.
2002,
Pubmed
Beaton,
Identification of a novel N-methyl-D-aspartate receptor population in the rat medial thalamus.
1992,
Pubmed
Bigge,
Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists.
1993,
Pubmed
Binns,
Visual experience alters the molecular profile of NMDA-receptor-mediated sensory transmission.
1999,
Pubmed
Buller,
The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
1994,
Pubmed
,
Xenbase
Buller,
Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
Cheung,
Structure-activity relationships of competitive NMDA receptor antagonists.
1996,
Pubmed
Choi,
Antagonizing excitotoxicity: a therapeutic strategy for stroke?
1998,
Pubmed
Christie,
Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
2000,
Pubmed
Dingledine,
The glutamate receptor ion channels.
1999,
Pubmed
Durand,
Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C.
1992,
Pubmed
,
Xenbase
Harris,
Cortically evoked excitatory synaptic transmission in the cat red nucleus is antagonised by D-AP5 but not by D-AP7.
1992,
Pubmed
Hollmann,
Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.
1993,
Pubmed
,
Xenbase
Hrabetova,
Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction.
2000,
Pubmed
,
Xenbase
Ikeda,
Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel.
1992,
Pubmed
,
Xenbase
Ishii,
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
1993,
Pubmed
,
Xenbase
Kendrick,
Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits.
1996,
Pubmed
Laube,
Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit.
1997,
Pubmed
Laurie,
Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
1994,
Pubmed
Minami,
Characterization of the glutamatergic system for induction and maintenance of allodynia.
2001,
Pubmed
Monaghan,
Molecular determinants of NMDA receptor pharmacological diversity.
1998,
Pubmed
Monaghan,
Identification and properties of N-methyl-D-aspartate receptors in rat brain synaptic plasma membranes.
1986,
Pubmed
Monaghan,
Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine.
1988,
Pubmed
Monyer,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
1994,
Pubmed
Nakanishi,
Glutamate receptors: brain function and signal transduction.
1998,
Pubmed
Vicini,
Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
1998,
Pubmed
Watanabe,
Distinct spatio-temporal distributions of the NMDA receptor channel subunit mRNAs in the brain.
1993,
Pubmed
Watanabe,
Developmental changes in distribution of NMDA receptor channel subunit mRNAs.
1992,
Pubmed
